Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02910180 · ClinicalTrials.gov registry record

Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders

A clinical trial of Ischemic Stroke and Cerebrovascular Diseases, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
900
Enrollment target
1
Study location

NCT02910180: Recruiting study of Ischemic Stroke and Cerebrovascular Diseases, sponsored by Cedars-Sinai Medical Center.

NCT02910180 is a study of Ischemic Stroke and Cerebrovascular Diseases that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 900 participants, below the 1,450-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02910180, a study of Ischemic Stroke and Cerebrovascular Diseases, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
900 participants
Enrollment target
1
Study location

Study Summary

This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigators to better categorize groups of patients, understand the underlying etiology of these pathologies, identify markers that are associated with favorable or poor outcomes, and track changes that occur during the natural course of the disease or with treatment. This is a prospective observational study which will use samples from such patients to create this library which can be used to explore these questions in the future.

Conditions Studied

Ischemic Stroke Cerebrovascular Diseases Repository

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2016-09
Est. Completion 2030-12
Cedars-Sinai Medical Center

339 total trials

What NCT02910180 shows while recruiting

NCT02910180 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,450-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (38% lower).

The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT02910180 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02910180 about?

NCT02910180 is a clinical study titled "Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders". This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigat...

What is the current status of trial NCT02910180?

This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2016-09. Estimated completion is 2030-12.

What conditions does trial NCT02910180 study?

This clinical trial studies the following conditions: Ischemic Stroke, Cerebrovascular Diseases, Repository.

Who is sponsoring clinical trial NCT02910180?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02910180 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02910180's enrollment target sits among peer trials

900 10th of 66 higher than 57 of 66 other Ischemic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT02910180

Source: ClinicalTrials.gov NCT02910180, the US trial registry maintained by the National Library of Medicine. NCT02910180 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.